Autopsy report · NCT00363025
A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.
Cause of deathNo reason given
Life of this trial
- Registered 6 years 9 months after it had already started.
- Ran for about 6 years 5 months before it stopped.
- 465 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Acute Leukemia French Association
- Sponsor type
- University, hospital or other
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Two post-remission strategies; Idarubicin versus daunorubicin
- Participants
- 465
- Sites
- 13
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.